| May 1, 2025 | Therini Bio | $39.0M Series A | Houman Ashrafian | Cambridge Innovation Capital, Dolby Family Ventures, MP Healthcare Venture Management, Hakan Goker, Sanofi Ventures, SV Health Investors, Howard Fillit, Thomas Michael Thestrup, Apollo Health Ventures, Eli Lilly and Company, Foundation for a Better World, MRL Ventures Fund, SV Health Investors |
| Feb 1, 2024 | Sudo Biosciences | $30.0M Series B | — | 5AM Ventures, Access Biotechnology, Adjuvant Capital, Andreessen Horowitz, Frazier Healthcare Partners, Brendan Bulik-Sullivan, Pureos Bioventures, Sanofi Ventures, Versant Ventures, Vincent Brichard, Jonathan Behr, Juergen Eckhardt, Matthias Kleinz |
| Oct 1, 2023 | AstronauTx | $59.0M Series A | Marianne Uteng | Atlas Venture, Bioluminescence Ventures, Brandon Capital Partners, David Schenkein, Lightstone Ventures, Morgenthaler Ventures, Michele Park, Novartis Venture Fund, SV Health Investors, Bill Gates, Josh Resnick, Todd Foley, Jonathan Tobin, Bristol Myers Squibb, Laurence Barker, LSP, MPM Capital |
| Jun 2, 2023 | Violet Therapeutics | $10.6M Seed | Jonathan Behr, Atsushi Usami | Meredith Fisher, Shunichiro Matsumoto |
| Apr 1, 2023 | Therini Bio | $36.0M Series A | Sanofi Ventures, Dementia Discovery Fund, MRL Ventures Fund, Houman Ashrafian | Cambridge Innovation Capital, Dolby Family Ventures, MP Healthcare Venture Management, Hakan Goker, SV Health Investors, Howard Fillit, Eli Lilly and Company, Foundation for a Better World |
| Mar 1, 2023 | QurAlis | $88.0M Series B | Sanofi Ventures, Droia Ventures, Cillian King | 15th Rock Ventures, Amadeus Capital Partners, AMR Action Fund, Oscar Slotboom, Brandon Capital Partners, EQT Life Sciences, Scott Biller, INKEF Capital, Mission BioCapital, MP Healthcare Venture Management, Northpond Ventures, Polaris Partners, ALS Investment Fund, Amgen Ventures, Dolby Family Ventures, LS Polaris Innovation Fund, Mission Bay Capital, Mitsui & Co. Global Investment, MP Healthcare Venture Management, Sanford Biosciences |
| Feb 1, 2023 | Cerevance | $51.0M Series B | — | ARCH Venture Partners, Bioluminescence Ventures, David Schenkein, Issi Rozen, GV, Lux Capital, Morgenthaler Ventures, SV Health Investors, Bill Gates, Dolby Family Ventures, Foresite Capital, Gates Frontier, Lightstone Ventures, Takeda Ventures, UPMC Enterprises |
| May 31, 2022 | Harness Therapeutics | $5.8M Seed Extension | Mary Canning | Christian Jung |
| Dec 1, 2021 | AviadoBio | $78.0M Series A | New Enterprise Associates, Tim Funnell | Advent Life Sciences, F-Prime Capital, Johnson & Johnson Innovation, Lifers, Philip Scheltens |
| Nov 1, 2021 | Nitrase Therapeutics | $7.0M Series A | — | AbbVie Ventures, Canaan Partners, INKEF Capital, Roche Venture Fund, Soffinova Partners, AbbVie Ventures, Alexandria Venture Investments, Bristol Myers Squibb, Mission Bay Capital |
| Jun 2, 2021 | Harness Therapeutics | $12.9M Seed | Christian Jung, Rob Woodman | — |
| May 1, 2021 | Therini Bio | $17.0M Seed | Sanofi Ventures, Christine Brennan, SV Health Investors | Cambridge Innovation Capital, Dolby Family Ventures, MP Healthcare Venture Management, Hakan Goker, Foundation for a Better World |
| Apr 1, 2021 | Alchemab Therapeutics | $83.0M Series A | Andrew Levin | RA Capital, Soffinova Partners, SV Health Investors, Danhua Capital, Data Collective, Lightstone Ventures, Houman Ashrafian |
| May 1, 2020 | QurAlis | $42.0M Series A | INKEF Capital, Mission BioCapital, Jonathan Behr, Luc Dochez, Amy Schulman | Amadeus Capital Partners, AMR Action Fund, Oscar Slotboom, EQT Life Sciences, Polaris Partners, Amgen Ventures, Dolby Family Ventures, Mitsui & Co. Global Investment, MP Healthcare Venture Management, Sanford Biosciences |
| Apr 1, 2020 | Cerevance | $65.0M Series B | — | ARCH Venture Partners, G2VP, Issi Rozen, GV, Kleiner Perkins, Lux Capital, Bill Gates, Foresite Capital, Lightstone Ventures, Takeda Ventures |
| Apr 1, 2020 | Nitrase Therapeutics | $38.0M Series A | Soffinova Partners, Margarita Chavez | AbbVie Ventures, Canaan Partners, INKEF Capital, Roche Venture Fund, Alexandria Venture Investments, Jonathan Behr, Mission Bay Capital |
| Sep 27, 2019 | Ribometrix | $7.8M Other Equity | Dementia Discovery Fund, Illumina Ventures | — |
| Jul 1, 2019 | Therini Bio | $9.0M Seed | Dolby Family Ventures, Laurence Barker | Cambridge Innovation Capital, MP Healthcare Venture Management, Hakan Goker, Sanofi Ventures, SV Health Investors |
| Nov 1, 2018 | Ribometrix | $30.0M Series A | M Ventures (Merck) | AbbVie Ventures, Hatteras Venture Partners, Hakan Goker, AbbVie Ventures, Alexandria Venture Investments, Amgen Ventures, Illumina Ventures, MP Healthcare Venture Management, Pappas Capital, SV Health Investors |
| Jul 25, 2018 | Alector | $133.0M Series E | — | AbbVie Ventures, Amgen Ventures, Casdin Capital, Deerfield Management, Euclidean Capital, Federated Kaufmann Fund, Foresite Capital, Google Ventures, Lilly Asia Ventures, Mission Bay Capital, MRL Ventures Fund, New Leaf Venture Partners, OrbiMed, Perceptive Advisors, Polaris Partners, Section 32 |
| Oct 1, 2017 | Ribometrix | $8.0M Seed | Hatteras Venture Partners, Michael Solomon | AbbVie Ventures, Hakan Goker, John Gustofson, Alexandria Venture Investments, MP Healthcare Venture Management |
| Jun 28, 2017 | Mitoconix Bio | $20.0M Series A | Taro Inaba | Jonathan Tobin, OrbiMed, RMGP Bio-Pharma |
| May 3, 2017 | Cerevance | $5.0M Other Equity | tetsuyuki maruyama | — |
| Mar 15, 2017 | Autifony Therapeutics | $1.6M Other Equity | tetsuyuki maruyama, Innovate UK | — |
| Jan 1, 2016 | Alector | $30.0M Series D | Dementia Discovery Fund | Atlas Venture, Biomatics Capital Partners, Flagship Ventures, OrbiMed, Polaris Partners, AbbVie Ventures, Amgen Ventures, Google Ventures, Mission Bay Capital, MRL Ventures Fund, Polaris Partners, Topspin Partners |
